source
- Acelyrin founder Shao-Lee Lin emerges at Cue, as it becomes latest to license from ChinaCue Biopharma announced a reboot Thursday afternoon, bringing in notable biotech executive Shao-Lee Lin as well as a new allergy asset developed in Taiwan and mainland China. The Boston-based biote…Endpoints · 4mo ago↗ source
- Save the date: Premium subscriber-exclusive Post-Hoc LiveQ1 earnings recap with Endpoints News After a deal-heavy first quarter, earnings season is in full swing. We're breaking down the news and trends from Big Pharma's first-quarter calls on a special…Endpoints · 4mo ago↗ source
- FDA approval for Alzheimer's agitation drug; Esperion goes private in $1.1B deal🟢 FDA approves Axsome Therapeutics' Auvelity for Alzheimer’s agitation: Axsome said up to 76% of patients with Alzheimer’s disease have agitation, which is characterized by pacing, restlessness an…